View in EDS HTML Full Text PDF Full Text

The nuclear receptor REV-ERBα is implicated in the alteration of β-cell autophagy and survival under diabetogenic conditions.

Saved in:
Bibliographic Details
Title: The nuclear receptor REV-ERBα is implicated in the alteration of β-cell autophagy and survival under diabetogenic conditions.
Authors: Brown MR; Department of Physiology and Biomedical Engineering, Mayo Clinic School of Medicine, Mayo Clinic, Rochester, MN, USA., Laouteouet D; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France., Delobel M; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France., Villard O; Laboratory of Cell Therapy for Diabetes (LTCD), PRIMS facility, Institute for Regenerative Medicine and Biotherapy (IRMB), University hospital of Montpellier, Montpellier, France.; Department of Endocrinology, Diabetes, and Nutrition, University Hospital of Montpellier, Montpellier, France., Broca C; Laboratory of Cell Therapy for Diabetes (LTCD), PRIMS facility, Institute for Regenerative Medicine and Biotherapy (IRMB), University hospital of Montpellier, Montpellier, France., Bertrand G; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France., Wojtusciszyn A; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.; Laboratory of Cell Therapy for Diabetes (LTCD), PRIMS facility, Institute for Regenerative Medicine and Biotherapy (IRMB), University hospital of Montpellier, Montpellier, France.; Department of Endocrinology, Diabetes, and Nutrition, University Hospital of Montpellier, Montpellier, France., Dalle S; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France., Ravier MA; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France., Matveyenko AV; Department of Physiology and Biomedical Engineering, Mayo Clinic School of Medicine, Mayo Clinic, Rochester, MN, USA. Matveyenko.Aleksey@mayo.edu.; Division of Endocrinology, Metabolism, Diabetes, and Nutrition, Department of Medicine, Mayo Clinic, Rochester, MN, USA. Matveyenko.Aleksey@mayo.edu., Costes S; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France. safia.costes@igf.cnrs.fr.
Source: Cell death & disease [Cell Death Dis] 2022 Apr 15; Vol. 13 (4), pp. 353. Date of Electronic Publication: 2022 Apr 15.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35428762
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The nuclear receptor REV-ERBα is implicated in the alteration of β-cell autophagy and survival under diabetogenic conditions.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Brown+MR%22">Brown MR</searchLink>; Department of Physiology and Biomedical Engineering, Mayo Clinic School of Medicine, Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Laouteouet+D%22">Laouteouet D</searchLink>; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Delobel+M%22">Delobel M</searchLink>; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Villard+O%22">Villard O</searchLink>; Laboratory of Cell Therapy for Diabetes (LTCD), PRIMS facility, Institute for Regenerative Medicine and Biotherapy (IRMB), University hospital of Montpellier, Montpellier, France.; Department of Endocrinology, Diabetes, and Nutrition, University Hospital of Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Broca+C%22">Broca C</searchLink>; Laboratory of Cell Therapy for Diabetes (LTCD), PRIMS facility, Institute for Regenerative Medicine and Biotherapy (IRMB), University hospital of Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Bertrand+G%22">Bertrand G</searchLink>; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Wojtusciszyn+A%22">Wojtusciszyn A</searchLink>; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.; Laboratory of Cell Therapy for Diabetes (LTCD), PRIMS facility, Institute for Regenerative Medicine and Biotherapy (IRMB), University hospital of Montpellier, Montpellier, France.; Department of Endocrinology, Diabetes, and Nutrition, University Hospital of Montpellier, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Dalle+S%22">Dalle S</searchLink>; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Ravier+MA%22">Ravier MA</searchLink>; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Matveyenko+AV%22">Matveyenko AV</searchLink>; Department of Physiology and Biomedical Engineering, Mayo Clinic School of Medicine, Mayo Clinic, Rochester, MN, USA. Matveyenko.Aleksey@mayo.edu.; Division of Endocrinology, Metabolism, Diabetes, and Nutrition, Department of Medicine, Mayo Clinic, Rochester, MN, USA. Matveyenko.Aleksey@mayo.edu.<br /><searchLink fieldCode="AU" term="%22Costes+S%22">Costes S</searchLink>; Institute of Functional Genomics, University of Montpellier, CNRS, INSERM, Montpellier, France. safia.costes@igf.cnrs.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2022 Apr 15; Vol. 13 (4), pp. 353. <i>Date of Electronic Publication: </i>2022 Apr 15.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35428762
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41419-022-04767-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 353
    Titles:
      – TitleFull: The nuclear receptor REV-ERBα is implicated in the alteration of β-cell autophagy and survival under diabetogenic conditions.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Brown MR
      – PersonEntity:
          Name:
            NameFull: Laouteouet D
      – PersonEntity:
          Name:
            NameFull: Delobel M
      – PersonEntity:
          Name:
            NameFull: Villard O
      – PersonEntity:
          Name:
            NameFull: Broca C
      – PersonEntity:
          Name:
            NameFull: Bertrand G
      – PersonEntity:
          Name:
            NameFull: Wojtusciszyn A
      – PersonEntity:
          Name:
            NameFull: Dalle S
      – PersonEntity:
          Name:
            NameFull: Ravier MA
      – PersonEntity:
          Name:
            NameFull: Matveyenko AV
      – PersonEntity:
          Name:
            NameFull: Costes S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 04
              Text: 2022 Apr 15
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2041-4889
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Cell death & disease
              Type: main
ResultId 1